AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 29490680
Drug: Usual medications
RxNorm normalized name: HYDROGEN PEROXIDE 5 mg in 100 mL TOPICAL LIQUID [USUALKLENZ DISINFECTANTSPRAY]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual medications
Trial: 21931653
Drug: Donepezil (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Donepezil (5 mg per day)
Trial: 21931653
Drug: Donepezil (single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Donepezil (single 5 mg dose)
Trial: 16533939
Drug: Rosuvastatin 40
RxNorm normalized name: rosuvastatin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosuvastatin 40 mg/d
Trial: 11495620
Drug: Antibiotic administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Antibiotic administration via the catheter
Trial: 9512207
Drug: Doxapram (3.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxapram (3.5 mg kg(‐1) bolus followed by 1 mg kg(‐1) h(‐1) infusion)
Trial: 8893893
Drug: First-line paclitaxel
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: First-line paclitaxel (200 mg/m2 as a 3-hour infusion) followed by second-line doxorubicin (75 mg/m2 as a bolus injection)
Trial: 8893893
Drug: Second-line doxorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Second-line doxorubicin (75 mg/m2 as a bolus injection) followed by first-line paclitaxel (200 mg/m2 as a 3-hour infusion)
Trial: 7000105
Drug: Probenecid 0.5
RxNorm normalized name: colchicine-probenecid 0.5 mg-500 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probenecid 0.5 g
Trial: 7000105
Drug: Probenecid 1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probenecid 1.0 g
Trial: 7000105
Drug: Probenecid 0.5
RxNorm normalized name: colchicine-probenecid 0.5 mg-500 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probenecid 0.5 g (without pethidine premedication)
Trial: 7000105
Drug: Probenecid (without
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probenecid (without pethidine premedication, thiopentone 4 mg kg‐1)
Trial: 28392509
Drug: Reference formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reference formulation (25-mg agomelatine)
Trial: 25575258
Drug: Gastrografin (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gastrografin (100 mL administered enterally)
Trial: 25889222
Drug: COBRA Slim
RxNorm normalized name: benzalkonium chloride Topical Foam [DigiClean Slim-Line]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: COBRA Slim (MTX with prednisone bridging, starting at 30 mg and tapered to 5 mg daily from week 6)
Trial: 25889222
Drug: MTX-TSU (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MTX-TSU (15 mg of MTX weekly)
Trial: 18451718
Drug: NSAIDs (effervescent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NSAIDs (effervescent aspirin)
Trial: 10851109
Drug: Nimesulide (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nimesulide (100 mg twice daily for 10 days)
Trial: 2015162
Drug: Ibuprofen (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen (600 mg three times daily for 10 days)
Trial: 9507415
Drug: No treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment (idiopathic cases)
Trial: 7810816
Drug: Praziquantel 40
RxNorm normalized name: PRAZIQUANTEL 40 mg in 1 mL ORAL SOLUTION [A Vial]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Praziquantel 40 mg/kg as a single oral dose
Trial: 2467132
Drug: Amlodipine 5
RxNorm normalized name: amlodipine 5 MG
DrugBank: Amlodipine (DB00381)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amlodipine 5 mg single oral dose
Trial: 29198820
Drug: Oral amoxicillin
RxNorm normalized name: amoxicillin Oral Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral amoxicillin plus resveratrol (AX + RV)
Trial: 29198820
Drug: Oral amoxicillin
RxNorm normalized name: amoxicillin Oral Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral amoxicillin plus placebo (AX + placebo)
Trial: 28743659
Drug: Reflexology intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Reflexology intervention (four weekly sessions, caregiver-delivered, 30-minute protocol)
Trial: 26367865
Drug: Ibudilast 40
RxNorm normalized name: ibudilast
DrugBank: Ibudilast (DB05266)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Ibudilast 40 mg twice daily for 8 weeks
Trial: 12699517
Drug: Rocuronium 0.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rocuronium 0.6 mg kg(‐1) and lidocaine 1.5 mg kg(‐1)
Trial: 11271285
Drug: Histidine‐Tryptophane‐Ketoglutarate (HTK)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Histidine‐Tryptophane‐Ketoglutarate (HTK) solution
Trial: 11271285
Drug: Euro‐Collins (EC)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Euro‐Collins (EC) solution
Trial: 2853765
Drug: Lisinopril (20‐80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lisinopril (20‐80 mg/day)
Trial: 2853765
Drug: Atenolol (50‐200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol (50‐200 mg/day)
Trial: 23747044
Drug: Clopidogrel treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel treatment with high residual platelet reactivity (RPR) diagnosed on P2Y₁₂ reaction units >230
Trial: 23747044
Drug: Good responders
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Good responders to clopidogrel treatment
Trial: 30633139
Drug: Riboflavin 400
RxNorm normalized name: riboflavin 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Riboflavin 400 mg
Trial: 24905030
Drug: 0.3 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.3 mg/kg robatumumab followed by 10 mg/kg biweekly in P2
Trial: 24905030
Drug: 10 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg/kg robatumumab in P2
Trial: 24905030
Drug: 0.3 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.3 mg/kg robatumumab
Trial: 12396296
Drug: Liquid Gaviscon
RxNorm normalized name: Gaviscon Oral Liquid Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liquid Gaviscon (20 mL)
Trial: 12396296
Drug: Gaviscon Advance
RxNorm normalized name: Gaviscon
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gaviscon Advance (10 mL)
Trial: 8990771
Drug: Intravenous immunoglobulin
RxNorm normalized name: Intravenous immunoglobulin (IVIg)
DrugBank: Human immunoglobulin G (DB00028)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous immunoglobulin (IVIG) 500 mg/kg
Trial: 7284972
Drug: Weekly oral
RxNorm normalized name: elagolix
DrugBank: Elagolix (DB11979)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Weekly oral 5-fluorouracil (5-FU)
Trial: 7284972
Drug: Weekly intravenous
RxNorm normalized name: elagolix
DrugBank: Elagolix (DB11979)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Weekly intravenous 5-fluorouracil (5-FU)
Trial: 23974035
Drug: Weight loss
RxNorm normalized name: HERBAL WEIGHT LOSS AID
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weight loss only treatment (WL)
Trial: 21329622
Drug: Hyoscine butylbromide
RxNorm normalized name: Hyoscine butylbromide
DrugBank: Butylscopolamine (DB09300)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyoscine butylbromide tablets
Trial: 21329622
Drug: Hyoscine butylbromide
RxNorm normalized name: Hyoscine butylbromide
DrugBank: Butylscopolamine (DB09300)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyoscine butylbromide capsules
Trial: 19433701
Drug: Exposure to
RxNorm normalized name: Wong To Yick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exposure to small branded promotional items for Lipitor (atorvastatin)
Trial: 16724678
Drug: Eicosapentaenoic acid
RxNorm normalized name: eicosapentaenoic acid
DrugBank: Icosapent (DB00159)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Eicosapentaenoic acid (EPA) at a dose of 2400 mg/day for 12 weeks
Trial: 30412630
Drug: Low molecular
RxNorm normalized name: Low molecular weight heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low molecular weight heparin (enoxaparin)
Trial: 9143868
Drug: Controlled diffusion
RxNorm normalized name: LUNG DIFFUSION GAS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Controlled diffusion diltiazem (180 mg taken in the morning)
Trial: 9143868
Drug: Conventional release
RxNorm normalized name: Product manufactured as conventional release gas for inhalation (product)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional release diltiazem (90 mg taken twice daily)
Trial: 7956413
Drug: Metaproterenol (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metaproterenol (1 mL 0.5% in 3 mL saline solution)
Trial: 7956413
Drug: Saline solution
RxNorm normalized name: Unisol 4 Saline Solution
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Saline solution (4 mL)
Trial: 3238472
Drug: Full-dose HB
RxNorm normalized name: Rho(D) immune globulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Full-dose HB vaccine (Group A, 69 infants)
Trial: 3238472
Drug: Half-dose HB
RxNorm normalized name: Citalopram Hydrobromide
DrugBank: Citalopram (DB00215)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Half-dose HB vaccine (Group B, 70 infants)
Trial: 23758673
Drug: Kivia powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Kivia powder (5.5 g daily for four weeks)
Trial: 12939876
Drug: Fenazid (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenazid (0.5 g daily for 2 months)
Trial: 12939876
Drug: Routine antituberculous
RxNorm normalized name: Peace Out Acne Hero Routine KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine antituberculous chemotherapy regimen including isoniazid
Trial: 10617523
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of problem solving treatment and antidepressant medication
Trial: 10617523
Drug: Problem solving
RxNorm normalized name: Solv X
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Problem solving treatment delivered by practice nurses
Trial: 10617523
Drug: Problem solving
RxNorm normalized name: Solv X
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Problem solving treatment delivered by general practitioners
Trial: 9169747
Drug: Whole-cell pertussis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whole-cell pertussis vaccine (wP)
Trial: 9169747
Drug: Acellular pertussis
RxNorm normalized name: Acellular pertussis vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acellular pertussis vaccine (aP-SB)
Trial: 9169747
Drug: Acellular pertussis
RxNorm normalized name: Acellular pertussis vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acellular pertussis vaccine (aP-CB)
Trial: 9169747
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (DT or unresponsive pertussis vaccine recipients)
Trial: 8466237
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg nebulised budesonide
Trial: 3512507
Drug: Antibiotic prophylaxis
RxNorm normalized name: STONE PROPHYLAXIS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotic prophylaxis (methicillin 2 g and netilmicin 200 mg, three doses)
Trial: 27681077
Drug: Synbiotic supplementation
RxNorm normalized name: Synotic
DrugBank: Fluocinolone acetonide (DB00591)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Synbiotic supplementation (daily capsule containing Lactobacillus acidophilus, Lactobacillus casei, Bifidobacterium bifidum at 2×10^9 CFU/g each plus 800 mg inulin) for 6 weeks
Trial: 24947504
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose of chlorogenic acids (412 μmol)
Trial: 24947504
Drug: Medium dose
RxNorm normalized name: TRIGLYCERIDES,MEDIUM CHAIN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medium dose of chlorogenic acids (635 μmol)
Trial: 24947504
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose of chlorogenic acids (795 μmol)
Trial: 22544046
Drug: Cyproheptadine 4
RxNorm normalized name: cyproheptadine 4 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyproheptadine 4 mg three times per day for 12 weeks
Trial: 15855489
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg infusion of isoniazid
Trial: 15855489
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg oral single dose of isoniazid
Trial: 15855489
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg oral single dose of isoniazid
Trial: 8524425
Drug: Sucralfate suspension
RxNorm normalized name: Sucralfate
DrugBank: Sucralfate (DB00364)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sucralfate suspension 2 g daily (twice daily for 6 months)
Trial: 18556965
Drug: Placebo (twice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (twice daily for 6 months)
Trial: 7048519
Drug: Cephalosporin (oral)
RxNorm normalized name: Cephalosporium roseum
DrugBank: Cephalosporium roseum (DB10932)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cephalosporin (oral)
Trial: 27206939
Drug: Evacetrapib 500
RxNorm normalized name: Evacetrapib
DrugBank: Evacetrapib (DB11655)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Evacetrapib 500 mg/d
Trial: 27206939
Drug: Evacetrapib plus
RxNorm normalized name: Evacetrapib
DrugBank: Evacetrapib (DB11655)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Evacetrapib plus statins (100 mg evacetrapib + simvastatin 40 mg/d, atorvastatin 20 mg/d, or rosuvastatin 10 mg/d)
Trial: 17553812
Drug: Piperacillin-tazobactam/amoxicillin-clavulanate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Piperacillin-tazobactam/amoxicillin-clavulanate
Trial: 9715790
Drug: Intranasal ANG
RxNorm normalized name: influenza A virus (H1N1) antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal ANG II (400 microg)
Trial: 9715790
Drug: Intravenous ANG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous ANG II (2.5 microg)
Trial: 2555803
Drug: Oxycodone (0.13
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxycodone (0.13 mg/kg)
Trial: 100808
Drug: Diphenhydramine (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diphenhydramine (100 mg)
Trial: 31446629
Drug: Sugar consumption
RxNorm normalized name: Invert Sugar
DrugBank: Invert sugar (DB09344)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sugar consumption restricted to less than 3% of total daily calories for 8 weeks
Trial: 30925951
Drug: Laparoscopic surgery
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Laparoscopic surgery combined with GnRH agonist (GnRH‐a)
Trial: 23688546
Drug: Low-dose adjuvanted
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose adjuvanted quadrivalent influenza vaccine (LD QIV-AS)
Trial: 23688546
Drug: Low-dose adjuvanted
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose adjuvanted trivalent influenza vaccine (LD TIV-AS)
Trial: 12234948
Drug: Intra-arterial vitamin
RxNorm normalized name: methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intra-arterial vitamin C (24 mg/min)
Trial: 8088389
Drug: General anaesthesia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: General anaesthesia (GA; n = 9) followed by intramuscular analgesics
Trial: 31440823
Drug: Aprepitant plus
RxNorm normalized name: Aprepitant
DrugBank: Aprepitant (DB00673)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aprepitant plus ondansetron (Arm-A: ondansetron 8 mg days 1-5 with aprepitant day 1: 125 mg, days 2-5: 80 mg)
Trial: 21417952
Drug: Dalteparin (5000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dalteparin (5000 IU once daily)
Trial: 15446778
Drug: Unfractionated heparin
RxNorm normalized name: Unfractionated heparin
DrugBank: Heparin (DB01109)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Unfractionated heparin (5000 IU twice daily)
Trial: 19877975
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of MPH and CLON
Trial: 9989682
Drug: Tocotrienol group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tocotrienol group (4 capsules daily, each containing 35 mg tocotrienols and 20 mg alpha-tocopherol)
Trial: 9989682
Drug: Placebo group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo group (4 capsules daily, each providing 20 mg alpha-tocopherol)
Trial: 6965333
Drug: Patients who
RxNorm normalized name: MAYZENT 0.25mg Tablet Starter Pack (For Patients Who Will Receive The 2mg Maintenance Dosage)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patients who underwent surgery after medical therapy failed
Trial: 31468659
Drug: Aleglitazar 150
RxNorm normalized name: Aleglitazar
DrugBank: Aleglitazar (DB08915)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aleglitazar 150 μg
Trial: 28726232
Drug: Topiramate 50
RxNorm normalized name: topiramate 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topiramate 50 mg/day for three months
Trial: 26484767
Drug: Topical Bimatoprost
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical Bimatoprost 0.01%
Trial: 23175769
Drug: Revaccination with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Revaccination with standard HBV vaccine series in HIV-1-infected initial nonresponders
Trial: 21293987
Drug: Triple therapy
RxNorm normalized name: MigreLief Triple Therapy with Puracol Caplet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple therapy until cessation of breastfeeding
Trial: 21293987
Drug: Short course
RxNorm normalized name: short ragweed pollen extract Sublingual Tablet [Ragwitek]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short course zidovudine monotherapy
Trial: 17943989
Drug: Pegylated interferon
RxNorm normalized name: Pegylated interferon alfa-2a
DrugBank: Peginterferon alfa-2a (DB00008)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pegylated interferon (PEG‐IFN) alpha‐2b (1.5 mug/kg/week) plus oral ribavirin (10.6 mg/kg/day) for 24 weeks (Group A)
Trial: 17943989
Drug: Pegylated interferon
RxNorm normalized name: Pegylated interferon alfa-2a
DrugBank: Peginterferon alfa-2a (DB00008)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pegylated interferon (PEG‐IFN) alpha‐2b (1.5 mug/kg/week) plus oral ribavirin (10.6 mg/kg/day) for 36 weeks (Group B)
Trial: 17943989
Drug: Pegylated interferon
RxNorm normalized name: Pegylated interferon alfa-2a
DrugBank: Peginterferon alfa-2a (DB00008)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pegylated interferon (PEG‐IFN) alpha‐2b (1.5 mug/kg/week) plus oral ribavirin (10.6 mg/kg/day) for 48 weeks (Group C)
Trial: 17943989
Drug: Control group:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group: Pegylated interferon (PEG‐IFN) alpha‐2b (1.5 mug/kg/week) plus oral ribavirin (10.6 mg/kg/day) for a fixed duration of 48 weeks
Trial: 14764787
Drug: Testosterone enanthate
RxNorm normalized name: Testosterone Enanthate
DrugBank: Testosterone enanthate (DB13944)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Testosterone enanthate (TE) 25 mg/wk
Trial: 14764787
Drug: Testosterone enanthate
RxNorm normalized name: Testosterone Enanthate
DrugBank: Testosterone enanthate (DB13944)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Testosterone enanthate (TE) 50 mg/wk
Trial: 14764787
Drug: Testosterone enanthate
RxNorm normalized name: Testosterone Enanthate
DrugBank: Testosterone enanthate (DB13944)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Testosterone enanthate (TE) 125 mg/wk
Trial: 14764787
Drug: Testosterone enanthate
RxNorm normalized name: Testosterone Enanthate
DrugBank: Testosterone enanthate (DB13944)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Testosterone enanthate (TE) 600 mg/wk
Trial: 25015176
Drug: UMEC/VI 125/25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UMEC/VI 125/25 mcg
Trial: 25015176
Drug: UMEC 125
RxNorm normalized name: Umecta
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UMEC 125 mcg
Trial: 31747236
Drug: VI 25
RxNorm normalized name: VITRAKVI 25mg Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VI 25 mcg
Trial: 23089217
Drug: Organopathic medicines
RxNorm normalized name: Percy Medicine
DrugBank: Bismuth subsalicylate (DB01294)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Organopathic medicines (OM)
Trial: 23089217
Drug: Constitutional medicines
RxNorm normalized name: Percy Medicine
DrugBank: Bismuth subsalicylate (DB01294)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Constitutional medicines (CM)
Trial: 23089217
Drug: Combined homeopathic
RxNorm normalized name: Urtica urens homeopathic preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined homeopathic treatment (BCOM)
Trial: 19047814
Drug: Nasal saline
RxNorm normalized name: Nasal Saline
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nasal saline irrigation and tapered topical steroid
Trial: 27859588
Drug: Client-centered therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Client-centered therapy
Trial: 9403918
Drug: Client-centered therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Client-centered therapy with additional behavioral exposure treatment
Trial: 9403918
Drug: Client-centered therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Client-centered therapy and behavioral exposure treatment
Trial: 8478043
Drug: Low-dose chlorthalidone
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose chlorthalidone
Trial: 23099060
Drug: L-carnosine (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-carnosine (2 g/day)